The 2022 open enrollment period begins soon, kicking off the second year under the Cures Act. Eligible end stage renal disease (ESRD) patients will once again have the opportunity to choose coverage under a Medicare Advantage (MA) plan.
Get your copy of "How MA plans get ahead on kidney care," by completing this form.
Over 100,0001 people are newly diagnosed with ESRD annually, and many transition right from diagnosis to dialysis. On average, MA plans can expect a 112% MLR2 for each ESRD member. It doesn’t have to be this way.
Get ahead on kidney care. Download our “How MA plans get ahead on kidney care” Executive Q&A to learn more.
------
[1] Unites States Renal Data System. 2020 USRDS Annual Data Report Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2020. Volume 2. Chapter 2. Table 1.1 [2] https://www.ahip.org/wp-content/uploads/202003_AHIP-MA_ESRD-v03.pdf
